UY37052A - PROCESO DE PRODUCCIÓN DE UNA GONADOTROPINA CORIÓNICA EQUINA RECOMBINANTE (reCG): COMPOSICIÓN VETERINARIA Y USO - Google Patents
PROCESO DE PRODUCCIÓN DE UNA GONADOTROPINA CORIÓNICA EQUINA RECOMBINANTE (reCG): COMPOSICIÓN VETERINARIA Y USOInfo
- Publication number
- UY37052A UY37052A UY0001037052A UY37052A UY37052A UY 37052 A UY37052 A UY 37052A UY 0001037052 A UY0001037052 A UY 0001037052A UY 37052 A UY37052 A UY 37052A UY 37052 A UY37052 A UY 37052A
- Authority
- UY
- Uruguay
- Prior art keywords
- recg
- recombinant
- coromical
- gonadotropine
- veterinary
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title abstract 3
- 102000011022 Chorionic Gonadotropin Human genes 0.000 abstract 1
- 108010062540 Chorionic Gonadotropin Proteins 0.000 abstract 1
- 238000009007 Diagnostic Kit Methods 0.000 abstract 1
- 241000283073 Equus caballus Species 0.000 abstract 1
- 102000006771 Gonadotropins Human genes 0.000 abstract 1
- 108010086677 Gonadotropins Proteins 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 238000004113 cell culture Methods 0.000 abstract 1
- 229940015047 chorionic gonadotropin Drugs 0.000 abstract 1
- 230000013595 glycosylation Effects 0.000 abstract 1
- 238000006206 glycosylation reaction Methods 0.000 abstract 1
- 239000002622 gonadotropin Substances 0.000 abstract 1
- 229940094892 gonadotropins Drugs 0.000 abstract 1
- 229940088597 hormone Drugs 0.000 abstract 1
- 239000005556 hormone Substances 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 230000016087 ovulation Effects 0.000 abstract 1
- 239000013589 supplement Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Endocrinology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Reproductive Health (AREA)
- Gastroenterology & Hepatology (AREA)
- Plant Pathology (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Toxicology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Invención referida a la producción de una gonadotropina coriónica equina recombinante (reCG), a una composición veterinaria comprendiendo la reCG, su uso o de la composición. La reCG posee un perfil de glucosilación similar al de las gonadotropinas coriónicas comercialmente disponibles y exhibe un nivel de actividad in vivo correspondiente al eCG, similar al de las hormonas FSH y LH. Tiene aplicación a la biotecnología al campo de reproducción asistida veterinaria, es adecuada para el tratamiento veterinario, a la reproducción y a la ovulación de mamíferos, para la fabricación de kits de diagnóstico o como suplemento para el cultivo de células.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR102015032660-2A BR102015032660B1 (pt) | 2015-12-28 | 2015-12-28 | PROCESSO DE PRODUÇÃO DE UMA GONADOTROFINA CORIÔNICA EQUINA RECOMBINANTE (reCG): COMPOSIÇÃO VETERINÁRIA E USO |
Publications (1)
Publication Number | Publication Date |
---|---|
UY37052A true UY37052A (es) | 2017-05-31 |
Family
ID=59224027
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY0001037052A UY37052A (es) | 2015-12-28 | 2016-12-27 | PROCESO DE PRODUCCIÓN DE UNA GONADOTROPINA CORIÓNICA EQUINA RECOMBINANTE (reCG): COMPOSICIÓN VETERINARIA Y USO |
Country Status (6)
Country | Link |
---|---|
AR (1) | AR107198A1 (es) |
BR (1) | BR102015032660B1 (es) |
CO (1) | CO2018006654A2 (es) |
MX (1) | MX2018008013A (es) |
UY (1) | UY37052A (es) |
WO (1) | WO2017112987A1 (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR102019004147A2 (pt) * | 2019-02-28 | 2020-10-06 | Ouro Fino Saude Animal Participacoes S.A. | Gonadotrofina coriônica equina recombinante (recg) biologicamente ativa e processo para obtenção da mesma, composição veterinária e uso |
EP4021930A1 (en) | 2019-08-30 | 2022-07-06 | Syntex S.A. | Recombinant chorionic gonadotropin, procedure for preparation, pharmaceutical compositions and uses of the same |
AR117743A1 (es) | 2019-12-30 | 2021-08-25 | Univ Nacional Del Litoral Unl | MÉTODO DE OBTENCIÓN DE UNA LÍNEA CELULAR DE MAMÍFERO QUE EXPRESA UNA HORMONA GONADOTROFINA CORIÓNICA EQUINA RECOMBINANTE (reCG), LÍNEA CELULAR QUE EXPRESA reCG, MÉTODO DE PRODUCCIÓN A ESCALA DE reCG, reCG, FORMULACIONES QUE LA CONTIENEN, ÁCIDOS NUCLEICOS QUE CODIFICAN PARA reCG Y USOS |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AT403167B (de) | 1994-11-14 | 1997-11-25 | Immuno Ag | Selektion und expression von fremdproteinen mittels eines selektions-amplifikations-systems |
AU4964197A (en) * | 1996-11-12 | 1998-06-03 | Teikoku Hormone Mfg. Co., Ltd. | Recombinant single-stranded equine chorionic gonadotropin |
DE102007025107A1 (de) | 2007-05-23 | 2008-12-04 | Universität Leipzig | Arzneimittel zur Behandlung von Fertilitäts- und Schwangerschaftsstörungen und immunologisch-bedingten Erkrankungen und Transplantationen zur Anwendung in der Tiermedizin, insbesondere bei Pferden sowie Verfahren zur Herstellung |
AU2013296709B2 (en) | 2012-07-30 | 2018-03-08 | Trophogen Inc. | Glycoprotein hormone long-acting superagonists |
BR112015028737B1 (pt) * | 2013-05-16 | 2022-05-10 | Universidade De São Paulo - Usp | Métodos para a produção e/ou purificação de hormônios |
-
2015
- 2015-12-28 BR BR102015032660-2A patent/BR102015032660B1/pt not_active IP Right Cessation
-
2016
- 2016-10-24 MX MX2018008013A patent/MX2018008013A/es unknown
- 2016-10-24 WO PCT/BR2016/050267 patent/WO2017112987A1/pt active Application Filing
- 2016-12-27 AR ARP160104021A patent/AR107198A1/es unknown
- 2016-12-27 UY UY0001037052A patent/UY37052A/es not_active Application Discontinuation
-
2018
- 2018-06-27 CO CONC2018/0006654A patent/CO2018006654A2/es unknown
Also Published As
Publication number | Publication date |
---|---|
CO2018006654A2 (es) | 2018-07-10 |
BR102015032660B1 (pt) | 2019-05-28 |
MX2018008013A (es) | 2019-01-10 |
WO2017112987A1 (pt) | 2017-07-06 |
BR102015032660A2 (pt) | 2017-07-04 |
AR107198A1 (es) | 2018-03-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2020002269A1 (es) | Anticuerpo que se une a redil33; polinucleótido; vector; célula hospedadora; método para producir el anticuerpo; composición farmacéutica; producto de combinación; uso del anticuerpo para tratar una afección inflamatoria (divisional de la solicitud no. 201702433) | |
CL2018001512A1 (es) | Anticuerpos anti-cd73 humanizados. | |
NI201700128A (es) | Composiciones de acido obeticolico y metodos de uso. | |
CL2019000732A1 (es) | Tratamiento avv de la enfermedad de huntington. | |
BR112017013691A2 (pt) | composição compreendendo um polímero em multiestágio, seu método de preparação e seu uso | |
AR090973A1 (es) | Anticuerpos utiles para el diagnostico del cancer | |
EA201692292A1 (ru) | Соединения и композиции для стимулирования хондрогенеза | |
CO2018006654A2 (es) | Proceso de producción de una gonadotrofina coriónica equina recombinante (recg), composición veterinaria y uso | |
MX2018002319A (es) | Composiciones biofarmaceuticas. | |
CO2022010432A2 (es) | Método basado en tecnología leaper para el tratamiento de mucopolisacaridosis ih y composición | |
CL2021001209A1 (es) | Constructos de suministro para transcitosis y métodos relacionados | |
MX2016011367A (es) | Microorganismo recombinante que expresa analogos de avermectina y uso de los mismos. | |
MX2018009493A (es) | Uso combinado de al menos una endoproteasa y al menos una exoproteasa en un proceso simultaneo de sacarificacion y fermentacion (ssf) para mejorar la produccion de etanol. | |
WO2016048861A3 (en) | Heterocyclic compounds and use thereof | |
MX2018002921A (es) | Composicion de hormona foliculo-estimulante mamifera con estabilidad incrementada. | |
CL2018000076A1 (es) | Mejora del metabolismo de las microalgas de xilosa. | |
EA201791724A1 (ru) | Способ получения гонадотропина | |
CL2009001006A1 (es) | Compuestos derivados del acido 4-dimetil-aminobutirico; proceso de obtencion; composicion farmaceutica; y uso en el tratamiento o profilaxis de enfermedades tales como hiperglucemia, diabetes e hipertension entre otras. | |
AU2018253555A1 (en) | Process for the preparation of 4-amino-1-((1S,4R,5S)-2-fluoro-4,5-dihydroxy-3-hydroxymethyl-cyclopent-2-enyl)-1H-pyrimidin-2-one | |
EP3398609A4 (en) | PROCESS FOR THE PRODUCTION OF RECOMBINANT EQUINE CHORIONIC CHRONIC GONADOTROPHIN (RECG), VETERINARY COMPOSITION AND USE | |
UY38585A (es) | Gonadotropina coriónica equina recombinant (recg) biológicamente activa y proceso para obtenerla, composición veterinaria y uso | |
BR112017011513A2 (pt) | tratamento de condições oculares usando células progenitoras | |
WO2017123312A3 (en) | Composition and methods of using umbilical cord lining stem cells | |
AR111715A1 (es) | ANTICUERPOS ANTI-SIRPa | |
RU2014125665A (ru) | Способ наружного лечения микозов кожи |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
109 | Application deemed to be withdrawn |
Effective date: 20221212 |